Navigation Links
Research needed to learn which DCIS patients may be candidates for less invasive therapy
Date:9/25/2009

Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup. An independent panel convened by the NIH urged the scientific community to identify appropriate biomarkers and other prognostic factors to better predict the risk of developing breast cancer.

"Instead of treating all women diagnosed with DCIS, we need to determine which individuals are likely to develop invasive breast cancer and which will not," said Dr. Carmen Allegra, panel chair and Chief of Hematology and Oncology at the University of Florida. "If we could accurately predict this, we might save some women from undergoing unnecessary invasive treatments while achieving the same positive outcomes."

DCIS is a condition in which a spectrum of abnormal cells are found in the breast duct and have not spread outside the duct to other tissues in the breast. Since the advent of widespread screening mammography in the early to mid 1980's, rates of DCIS have increased sharply. It is estimated that more than one million U.S. women will be living with a prior diagnosis of DCIS by 2020.

Despite the connotations associated with the term carcinoma, DCIS is associated with ten-year survival rates close to 100% when treated with currently available therapies. These include breast-conserving surgery (local excision, with or without radiation), removal of the breast (mastectomy), and/or tamoxifen. It is important to stress that each of these treatment options has physical and emotional impacts to patients and should be weighed accordingly. The panel recognized that there are relatively few reliable data on the comparative effectiveness
'/>"/>

Contact: Lisa Ahramjian
AhramjianL@od.nih.gov
301-496-4999
NIH/National Institutes of Health, Office of Disease Prevention
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Research network based at University of Toronto gets $5 million boost to speed up cancer detection
2. AFOSRs basic research may lead to revolutionary new devices
3. New research network at McMaster aims to build a better eye
4. WPI receives $1.3 million in federal awards for ongoing research in the life sciences
5. Stem cell applications and research highlight NJITs first Research Cafe
6. NIH announces 115 awards to encourage high-risk research and innovation
7. New genetic research indicates Jewish priesthood has multiple lineages
8. Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research
9. UNC scientists garner new NIH awards for high risk, transformative research
10. Researchers identify new brain pathway for regulating weight and bone mass
11. McGill garners 19 Canada Research Chairs and more than $17 million in funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... and think, "Of course! Why didn,t I think of ... own invention, sparking ideas and building possibilities. This type ... Station Program Science Office,s new 15-book Researcher,s Guide Series. ... in orbit, their mental wheels may begin to speed ... propose new research and potentially make discoveries that they ...
(Date:7/21/2014)... Lgar,s team at the INRS nergie Matriaux Tlcommunications ... a spatial and temporal resolution greatly exceeding that ... a femtosecond laser source to shoot a molecular ... vinylidene. An article presenting the advancement was recently ... . , "The approach we developed combines ...
(Date:7/21/2014)... -- Why does the word "dog" have meaning? If ... friend understand you? , Kansas State University philosopher Elliott ... his latest research, which focuses on long-standing philosophical questions ... two other philosophers and a mathematician are collaborating to ... acquires meaning. , "If I order a cappuccino at ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2
... [Brown University] A computerized epidemiological model of the spread ... California in 2005 successfully predicted where 81.6 percent of human ... where the risk of infection turned out to be 39 ... research. The DYCAST software used in those predictions is now ...
... cells is a well-oiled machine with tiny protein motors hauling ... molecular motors are responsible for a variety of critical transport ... can put themselves into "energy save mode" to conserve cellular ... the cell, and when. A new study ...
... may not sound very glamorous, a new method of ... news for both confined animal operations and environmental groups, ... The method uses gas-permeable membrane technology that tests have ... in liquid manure in 20 days. The removed ammonium ...
Cached Biology News:Software predicted risk in California West Nile virus epidemic 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 3New technology could capture ammonia from liquid manure 2New technology could capture ammonia from liquid manure 3
(Date:7/17/2014)... , July 17, 2014  Vanda Pharmaceuticals Inc. ... focused on the development and commercialization of products for ... it will release results for the second quarter of ... opens. The Company will host a ... 7, 2014, during which Vanda management will discuss the ...
(Date:7/17/2014)...  Prana Biotechnology (NASDAQ: PRAN ; ASX: ... development program for Alzheimer,s disease. Professor ... Mental Health, The University of Melbourne, will today include ... in his presentation at the Alzheimer,s Association International Conference ... The presentation is entitled: "How to change and ...
(Date:7/17/2014)... all know, some optical devices can only work with ... polarizer is necessary to shift the polarization direction of ... half-wave plate, which constructed out of a birefringent material ... half-wave plate depends on the thickness of the crystal, ... a half-wave plate is difficulty to integrate on circuits. ...
(Date:7/17/2014)... , July 17, 2014  Exelixis, Inc. (Nasdaq: ... company. EXEL developed two cancer treatments cabozantinib (Cabo, Cometriq) ... active component. The company has a partnership with Roche ... to earn approval in the treatment of melanoma by ... week. Cabo is marketed and distributed in the U.S. ...
Breaking Biology Technology:Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2
... Inc. (TSX:SDI), a company developing products for the ... International Symposium on Intensive Care and Emergency Medicine ... feature a key scientific symposium entitled, "The Role ... thought leaders in the field of sepsis. Presentations ...
... - Up to $50 Million Potential Milestones plus Double ... Host Conference Call at 11:00 a.m. ET Today - ... Amex: NBY ), a mid-stage biopharmaceutical company ... of a wide range of infections without causing resistance, ...
... 23, 2009 Reston, Va. The American Institute ... for Composites (ASC) congratulate the winners of the inaugural ... Distinguished Professor of Mechanical and Aerospace Engineering at the ... A. Armstrong Distinguished Professor of Aeronautical and Astronautical Engineering ...
Cached Biology Technology:Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 3NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 4NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 5NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 6Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes Jr. Award 2
... fast and reliable automation for today's ... development laboratories. Staccato Mini-Workstations offer the ... basic liquid handling and material management ... either Caliper's time proven CLARA™ assay ...
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
... If particles in the submicron range ... development process, measurement and control of particle ... an analyzer that can reliably detect the ... The N5 Submicron Particle Size Analyzer uses ...
...
Biology Products: